Effects of allergen inhalation and oral glucocorticoid on concentrations of serum-soluble CD86 in allergic asthmatics
Authors:
- 31 May 2005
- journal article
- clinical trial
- Published by Elsevier in Clinical Immunology
- Vol. 115 (2) , 178-183
Abstract
No abstract availableKeywords
This publication has 22 references indexed in Scilit:
- Soluble CD86 protein in serum samples of patients with asthmaThorax, 2004
- Human plasma contains a soluble form of CD86 which is present at elevated levels in some leukaemia patientsLeukemia, 2002
- AsthmaNew England Journal of Medicine, 2001
- Molecular mechanisms of glucocorticoid action: what is important?Thorax, 2000
- The Complexities of T‐Cell Co‐stimulation: CD28 and BeyondImmunological Reviews, 1996
- Molecular mechanisms of steroid action in asthmaJournal of Allergy and Clinical Immunology, 1996
- Role of Transcriptional Activation of IκBα in Mediation of Immunosuppression by GlucocorticoidsScience, 1995
- B7-1 and B7-2 costimulatory molecules activate differentially the Th1/Th2 developmental pathways: Application to autoimmune disease therapyCell, 1995
- Early and late asthmatic reaction after allergen challengeRespiratory Medicine, 1994
- Effect of therapy on bronchial hyperresponsiveness in the long‐term management of asthmaClinical & Experimental Allergy, 1988